Vitalhub Corp's stock has seen mixed performance this week, reflecting both market trends and company developments.
Vitalhub Corp (VHI.TO) closed at C$7.19 on Friday, down 2.56% for the day but up slightly by 0.28% over the week. The healthcare technology company has been active in the market, especially following its recent acquisition announcement.
Advertisement
Vitalhub Corp
VHI.TO
VHI.TO
Vitalhub Corp
WealthAwesomeMarket cap
$448.51M
P/E
59.1x
52W high
$14.64
52W low
$6.46
1W change
+1.59%
Beta
0.80
Analyst Price Targets
Based on analyst covering VHI
Wall Street analysts forecast VHI stock price to rise 75.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.32
+75.1% Upside
Current Price
C$7.04
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VHI's historical volatility
30-Day Vol
30.0%
Annualized
90-Day Vol
34.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$5.89
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$6.63 | C$5.98 – C$7.36 |
| 60 trading days | C$6.25 | C$5.40 – C$7.24 |
| 90 trading days | C$5.89 | C$4.92 – C$7.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should monitor the company's integration of Buddy Healthcare and its impact on future growth, as well as how current stock performance aligns with market expectations.
Vitalhub's stock is currently trading at C$7.19, significantly below its 52-week high of C$14.64.
With a market cap of C$464 million and a P/E ratio of 61.17, Vitalhub is positioned in a high-growth sector, but its profitability and return on equity remain modest.
Bull case
The acquisition of Buddy Healthcare could improve Vitalhub's product offerings and market presence. This may lead to increased revenue growth and a boost in investor sentiment.
Bear case
Despite the acquisition, ongoing market volatility and a declining year-to-date performance might continue to affect investor confidence, especially if the integration does not deliver the expected results.
Recent Price Action
Vitalhub Corp's stock closed at C$7.19 on Friday, reflecting a daily decline of 2.56%. Over the past week, the stock has managed a slight increase of 0.28%, but it remains down 24.21% year-to-date. The stock's performance has been volatile, and this week’s movement can be attributed partially to investor reactions to the recent acquisition news.
Company News
Advertisement
On July 13, 2026, Vitalhub announced its acquisition of Buddy Healthcare, which is expected to strengthen its product portfolio and enhance its competitive position in the healthcare technology sector. Some analysts view this move positively, seeing potential for increased market share and revenue growth as a result of this strategic acquisition.
Technical Picture
From a technical standpoint, Vitalhub is currently trading below its 50-day moving average of C$7.30 and its 200-day moving average of C$8.47, indicating a bearish trend in the short to medium term. The stock has a beta of 0.80, suggesting it is less volatile than the broader market. The 52-week trading range has been between C$6.62 and C$14.64, with the current price representing about 7% of this range. Trading volume has also been lower than average, with the latest volume at 108,588 shares compared to the 20-day average of 223,158 shares.
Insider Activity
No recent insider activity has been reported for Vitalhub Corp, which may indicate stability in management and ownership as the company navigates its recent acquisition and market conditions.
Price Action Summary
Vitalhub Corp ended the week with a closing price of C$7.19, reflecting a daily drop of 2.56%. Investors are advised to stay informed on the company's progress post-acquisition and its implications for future performance.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
